Danaher Corporation (DHR) Gross Margin: 60.68%
Is Danaher Corporation’s gross margin high or low?
Danaher Corporation's gross margin of 60.68% is in line with its 5-year average of 59.48%, near the high end of its 5-year range (55.98%–60.95%).
The gross margin for Danaher Corporation (DHR) is 60.68% as of Wednesday, June 10, 2026. It is above its 12-month average by 0.77% (60.22%).
DHR Gross Margin Chart
DHR Average Gross Margin Chart
DHR Current vs Average Gross Margin Chart
DHR Gross Margin Metrics
GROSS MARGIN
60.68%
GROSS MARGIN AVG TTM
60.22%
GROSS MARGIN AVG 3Y
59.98%
GROSS MARGIN AVG 5Y
59.48%
GROSS MARGIN AVG 10Y
57.69%
GROSS MARGIN AVG 15Y
55.79%
GROSS MARGIN AVG 20Y
53.38%
CURRENT VS TTM AVG
+0.77%
CURRENT VS 3Y AVG
+1.16%
CURRENT VS 5Y AVG
+2.02%
CURRENT VS 10Y AVG
+5.19%
CURRENT VS 15Y AVG
+8.77%
CURRENT VS 20Y AVG
+13.67%
DHR Competitors' Gross Margin
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $130.25B | 60.68% | 60.22% | 59.98% | 59.48% |
| CVS Health Corporation (CVS) | $125.16B | 13.87% | 13.78% | 14.92% | 15.96% |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 68.75% | 62.23% | 59.55% | 57.82% |
| Pfizer Inc. (PFE) | $146.36B | 69.35% | 68.05% | 62.23% | 63.06% |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 66.29% | 66.73% | 66.82% | 67.04% |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 86.28% | 85.57% | 86.56% | 87.08% |
| Gilead Sciences, Inc. (GILD) | $151.21B | 79.35% | 78.55% | 78.10% | 78.28% |
| Abbott Laboratories (ABT) | $154.66B | 56.38% | 53.17% | 51.86% | 51.92% |
| Medtronic plc (MDT) | $103.04B | 65.02% | 65.17% | 65.34% | 65.75% |
| Elevance Health Inc. (ELV) | $87.43B | 23.16% | 26.70% | 26.59% | 26.68% |
Gross Margin Analysis
Gross Margin
60.7%
(Revenue - COGS) / Revenue
Danaher Corporation Gross Margin Formula & Definition
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation Gross Margin FAQ
- What is the gross margin for Danaher Corporation (DHR)?
- The gross margin for DHR stock is 60.68%.
- Is Danaher Corporation's gross margin high or low?
- Danaher Corporation's gross margin of 60.68% is in line with its 5-year average of 59.48%, near the high end of its 5-year range (55.98%–60.95%).
- What is the TTM average gross margin for Danaher Corporation (DHR)?
- The TTM average gross margin for DHR stock is 60.22%.
- What is the 3Y average gross margin for Danaher Corporation (DHR)?
- The 3Y average gross margin for DHR stock is 59.98%.
- What is the 5Y average gross margin for Danaher Corporation (DHR)?
- The 5Y average gross margin for DHR stock is 59.48%.
- What is the 10Y average gross margin for Danaher Corporation (DHR)?
- The 10Y average gross margin for DHR stock is 57.69%.
- What is the 15Y average gross margin for Danaher Corporation (DHR)?
- The 15Y average gross margin for DHR stock is 55.79%.
- What is the 20Y average gross margin for Danaher Corporation (DHR)?
- The 20Y average gross margin for DHR stock is 53.38%.
Danaher Corporation Gross Margin History
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 60.93% |
| 2024-12-31 | 59.50% |
| 2023-12-31 | 58.74% |
| 2022-12-31 | 60.76% |
| 2021-12-31 | 60.95% |
| 2020-12-31 | 55.98% |
| 2019-12-31 | 55.74% |
| 2018-12-31 | 55.75% |
| 2017-12-31 | 55.81% |
| 2016-12-31 | 55.58% |
| 2015-12-31 | 54.83% |
| 2014-12-31 | 52.67% |
| 2013-12-31 | 52.22% |
| 2012-12-31 | 51.74% |
| 2011-12-31 | 51.24% |
| 2010-12-31 | 50.19% |
| 2009-12-31 | 48.30% |
| 2008-12-31 | 47.04% |
| 2007-12-31 | 45.72% |
| 2006-12-31 | 44.22% |
| 2005-12-31 | 43.15% |
| 2004-12-31 | 41.99% |
| 2003-12-31 | 40.41% |
| 2002-12-31 | 39.02% |
| 2001-12-31 | 38.19% |
| 2000-12-31 | 42.66% |
| 1999-12-31 | 42.62% |
| 1998-12-31 | 41.15% |
| 1997-12-31 | 36.30% |
| 1996-12-31 | 35.36% |
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair